ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: SA-PO700

Renal Oxalosis in Adult Patients: A Relatively Common Entity of Often Unclear Etiology

Session Information

Category: Pathology and Lab Medicine

  • 1602 Pathology and Lab Medicine: Clinical

Authors

  • Yang, Yihe, Northwell Health, Bayside, New York, United States
  • Sharma, Purva D., Northwell Health, Bayside, New York, United States
  • Nair, Vinay, Northwell Health, Bayside, New York, United States
  • Jhaveri, Kenar D., Northwell Health, Bayside, New York, United States
  • Malieckal, Deepa A., Northwell Health, Bayside, New York, United States
  • Wanchoo, Rimda, Northwell Health, Bayside, New York, United States
  • Rosenstock, Jordan L., Northwell Health, Bayside, New York, United States
  • Bijol, Vanesa, Northwell Health, Bayside, New York, United States
Background

The prevalence, manifestation and outcome of secondary oxalate nephropathy have not been extensively studied.

Methods

Retrospectively reviewed kidney biopsy cases with oxalate deposition (7/1/2017-12/31/2018).

Results

The prevalence of oxalate deposition on a kidney biopsy was 4.07%(25/615). Prior to biopsy, oxalate was anticipated in only 1 case. The etiology of oxalosis was clarified retrospectively in 14 cases, most commonly due to GI surgery (n=10) and increased oxalate intake (n=4). In 11 cases, etiology remained unknown, although at least 3 cases were exposed to antibiotics associated with secondary oxalosis. There was no significant clinical/pathological or survival difference between known vs. unknown cause groups. Multivariate COX regression showed that Cr at the time of biopsy (HR1.79,95%CI 0.71-4.51), background histological chronicity change(HR1.82, 95%CI 0.70-4.72) and oxalate density (HR2.27,95%CI 0.49-10.55) are associated with ESRD and patient death(-2LogLikelihood: 20.15 to 16.99,forward selection).

Conclusion

Oxalate deposition is common but rarely anticipated biopsy finding. Nephrologists need to consider surgical history and other secondary causes of oxalosis as causes of AKI and CKD.